How Big Pharma Rigged the Patent System
Back in March, the Patent Office of India denied an application from Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson)...
Addressing the nation during his State of the Union speech, President Joe Biden took aim at an injustice that touches the lives of most Americans—the absurdly high...
Brand drug manufacturers in the United States have developed strategies to thwart generic competition and preserve monopoly profits longer than policymakers intended. In doing...
As advocacy groups take a victory lap for moving lawmakers to finally allow Medicare to negotiate lower prices for 10 widely-used medicines, a new report detailed...
Overpatented, Overpriced:
This report analyzes the twelve best selling drugs in the United States and reveals that drugmakers file hundreds of patent applications – the...
